|本期目录/Table of Contents|

[1]夏 艳,金志军.长链非编码RNA牛磺酸上调基因1表达水平在Ⅰ~Ⅱ期宫颈癌诊断和预后中的作用[J].福建医科大学学报,2020,54(02):73-77.
 XIA Yan,JIN Zhijun.Evaluation of Long Non-coding RNA Taurine Upregulated Gene 1 ExpressionLevel in Diagnosis and Prognosis of Stage I-II Cervical Cancer[J].Journal of Fujian Medical University,2020,54(02):73-77.
点击复制

长链非编码RNA牛磺酸上调基因1表达水平在Ⅰ~Ⅱ期宫颈癌诊断和预后中的作用(PDF)
分享到:

《福建医科大学学报》[ISSN:1672-4194/CN:35-1192/R]

卷:
第54卷
期数:
2020年02期
页码:
73-77
栏目:
论著
出版日期:
2020-04-30

文章信息/Info

Title:
Evaluation of Long Non-coding RNA Taurine Upregulated Gene 1 ExpressionLevel in Diagnosis and Prognosis of Stage I-II Cervical Cancer
文章编号:
1672-4194(2020)02-0073-05
作者:
夏 艳1 金志军2
1.上海交通大学医学院 附属同仁医院妇产科,上海 200336; 2.第二军医大学 附属长征医院妇产科,上海 200003
Author(s):
XIA Yan1 JIN Zhijun2
1.Department of Gynaecology and Obstetrics, Tongren Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200336, China; 2.Department of Gynaecology and Obstetrics, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai 200003, China
关键词:
子宫肿瘤 RNA 牛磺酸 基因 诊断 预后
Keywords:
uterine neoplasms RNA taurine genes diagnosis prognosis
分类号:
R342.2; R737.33; R977
DOI:
-
文献标志码:
A
摘要:
目的 评估宫颈癌(CC)患者癌组织长链非编码RNA牛磺酸上调基因 1(lncRNA TUG1)的表达水平与CC诊断及预后的关系。 方法 前瞻性队列研究连续纳入137例接受手术治疗的CC患者。记录所有患者的人口学和临床病理特征并计算患者总体生存期(OS)。采用定量聚合酶链式反应(qPCR)检测CC患者癌组织和癌旁组织lncRNA TUG1的相对表达量。 结果 CC癌组织的lncRNA TUG1相对表达量显著高于配对的癌旁组织(P<0.001)。癌组织lncRNA TUG1表达水平与国际妇产科联盟(FIGO)分期(P=0.023)呈正相关。Kaplan-Meier(K-M)曲线显示,癌组织lncRNA TUG1高表达的患者OS显著低于癌组织lncRNA TUG1低表达的患者(P<0.001)。多元Cox比例风险模型分析显示,癌组织lncRNA TUG1高表达是CC患者OS较差的独立预测因素(P<0.001)。肿瘤大小≥4 cm(P<0.001)、FIGO Ⅲ期(P<0.001)、淋巴结转移阳性(P<0.001)和宫颈基层浸润深度≥2/3(P=0.002)也是CC患者OS较差的独立预测因素。 结论 癌组织lncRNA TUG1表达水平可作为辅助评估CC患者诊断和预后的潜在生物标志物。
Abstract:
Objective To evaluate the association of tumor tissue long non-coding RNA Taurine Upregulated Gene 1(lncRNA TUG1)expression with diagnosis and prognostic in surgical patients with cervical cancer(CC). Methods 137 CC patients were enrolled in this prospective cohort study. The baseline demographic information, clinical and pathological features of all patients were recorded. The overall survival(OS)was calculated, and the lncRNA TUG1 expression in CC tumor tissues as well as adjacent tissues of patients were detected by Quantitative Polymerase Chain Reaction. Results lncRNA TUG1 relative expression was higher in CC tumor tissues sample than paired adjacent tissues sample(P<0.001). Moreover, CC tissue lncRNA TUG1 expression was positively correlated with International Federation of Gynecology and Obstetrics(FIGO)stage(P=0.006). Kaplan Meier curve and Log Rank test showed that tumor tissue lncRNA TUG1 higher expressions were correlated with worse OS(P<0.001)compared to lower expression. In addition, multivariate Cox’s regression analysis revealed that tumor tissue lncRNA TUG1 high expression(P<0.001)was an independent factor for predicting worse OS. Tumor size ≥4 cm(P<0.001), FIGO Ⅱ stage(P<0.001), lymph node metastasis positive(P=0.001), and the cervical base infiltration depth ≥2/3(P=0.002)were also independent factor for predicting shorter OS. Conclusion lncRNA TUG1 expression in cancer tissue can be used as a potential biomarker for diagnosis and prognosis of patients with CC.

参考文献/References:

[1] Torre L A, Bray F, Siegel R L, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin,2015,65(2):87-108.
[2] Vaccarella S, Lortet-Tieulent J, Plummer M, et al. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors[J]. Eur J Cancer,2013,49(15):3262-3273.
[3] Franco E L, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection[J]. CMAJ,2001,164(7):1017-1025.
[4] Yu X, Zheng H, Chan M T, et al. BANCR: A cancer-related long non-coding RNA[J]. Am J Cancer Res,2017,7(9):1779-1787.
[5] Su S, Liu J, He K, et al. Overexpression of the long noncoding RNA TUG1 protects against cold-induced injury of mouse livers by inhibiting apoptosis and inflammation[J]. FEBS J,2016,283(7):1261-1274.
[6] Zhang M, Lu W, Huang Y, et al. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma[J]. J Mol Histol,2016,47(4):421-428.
[7] Li T, Liu Y, Xiao H, et al. Long non-coding RNA TUG1 promotes cell proliferation and metastasis in human breast cancer[J]. Breast Cancer,2017,24(4):535-543.
[8] Zhuo W, Kang Y. Lnc-ing ROR1-HER3 and Hippo signalling in metastasis[J]. Nat Cell Biol,2017,19(2):81-83.
[9] Qian Y, Liu D, Cao S, et al. Upregulation of the long noncoding RNA UCA1 affects the proliferation, invasion, and survival of hypopharyngeal carcinoma[J]. Mol Cancer,2017,16(1):68.
[10] Ren K, Li Z, Li Y, et al. Long noncoding RNA taurine-upregulated gene 1 promotes cell proliferation and invasion in gastric cancer via negatively modulating miRNA-145-5p[J]. Oncol Res,2017,25(5):789-798.
[11] Li Z, Shen J, Chan M T, et al. TUG1: a pivotal oncogenic long non-coding RNA of human cancers[J]. Cell Prolif,2016,49(4):471-475.
[12] Sun J, Ding C, Yang Z, et al. The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition[J]. J Transl Med,2016,14:42.
[13] Kuang D, Zhang X, Hua S, et al. Long non-coding RNA TUG1 regulates ovarian cancer proliferation and metastasis via affecting epithelial-mesenchymal transition[J]. Exp Mol Pathol,2016,101(2):267-273.
[14] Qin C F, Zhao F L. Long non-coding RNA TUG1 can promote proliferation and migration of pancreatic cancer via EMT pathway[J]. Eur Rev Med Pharmacol Sci,2017,21(10):2377-2384.
[15] Xu Y, Leng K, Li Z, et al. The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma[J]. Oncotarget,2017,8(39):65823-65835.
[16] Tan J, Qiu K, Li M, et al. Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells[J]. FEBS Lett,2015,589(20 Pt B):3175-3181.
[17] Wang P Q, Wu Y X, Zhong X D, et al. Prognostic significance of overexpressed long non-coding RNA TUG1 in patients with clear cell renal cell carcinoma[J]. Eur Rev Med Pharmacol Sci,2017,21(1):82-86.
[18] Zhu J, Shi H, Liu H, et al. Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis[J]. Oncotarget,2017,8(39):65253-65264.
[19] Li Z Q, Zou R, Ouyang K X, et al. An in vitro study of the long non-coding RNA TUG1 in tongue squamous cell carcinoma[J]. J Oral Pathol Med,2017,46(10):956-960.
[20] Wang Y, Yang T, Zhang Z, et al. Long non-coding RNA TUG1 promotes migration and invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells[J]. Cancer Sci,2017,108(5):859-867.
[21] Iliev R, Kleinova R, Juracek J, et al. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer[J]. Tumour Biol,2016,37(10):13385-13390.
[22] Zhai H Y, Sui M H, Yu X, et al. Overexpression of long non-coding RNA TUG1 promotes colon cancer progression[J]. Med Sci Monit,2016,22:3281-3287.

相似文献/References:

[1]段 娟,徐 燕,廖之君,等.核糖体小亚基蛋白S7对结肠癌细胞HCT116迁移的作用初探[J].福建医科大学学报,2016,50(05):281.
 DUAN Juan,XU Yan,LIAO Zhijun,et al.The Discussion of the Effect of Ribosomal Protein S7 on theMigration of Human Colon Cancer Cells HCT116[J].Journal of Fujian Medical University,2016,50(02):281.
[2]吴志贤,曾达武,林 苏,等.慢病毒载体介导siRNA沉默Id-1通过ERK1/2信号通路抑制裸鼠人肝癌移植瘤生长[J].福建医科大学学报,2018,52(02):69.
 WU Zhixian,ZENG Dawu,LIN Su,et al.Inhibitory Effect of Lentiviral Vector for siRNA of Id-1 on Human Transplanted Carcinoma in Nude Mice[J].Journal of Fujian Medical University,2018,52(02):69.
[3]黄丽萍(综述),何斐(审校).人类肿瘤中竞争性内源性RNA的生物学调控作用[J].福建医科大学学报,2018,52(04):276.
[4]梁诗琪,张香西,庄小津,等.B7-H3对人肝癌细胞生物学特性的影响及临床意义[J].福建医科大学学报,2019,53(03):137.
 LIANG Shiqi,ZHANG Xiangxi,ZHUANG Xiaojin,et al.Effect of B7-H3 on Biological Characteristics of Human Hepatoma Cells and its Clinical Significance[J].Journal of Fujian Medical University,2019,53(02):137.
[5]许静,李姗,蔡俊玮,等.miR|146a及其靶mRNA与初发Graves病的相关性研究[J].福建医科大学学报,2019,53(05):291.
 XU Jing,LI Shan,CAI Junwei,et al.Down|Regulation of p21 Expression[J].Journal of Fujian Medical University,2019,53(02):291.
[6]金曌,陈慧,程杨,等.lncRNA ANRIL在银屑病患者病变皮肤组织中的表达及其临床意义[J].福建医科大学学报,2019,53(05):303.
 JIN Zhao,CHEN Hui,CHENG Yang,et al.Long|chain Non|coding RNA ANRIL is Highly Expressed in LesionedSkin Tissue and is Positively Correlated with Disease Severity andInflammatory Cytokines Levels in Patients with Psoriasis[J].Journal of Fujian Medical University,2019,53(02):303.
[7]郑珞,陈佩芳.子宫体恶性血管周围上皮样细胞肿瘤1例报告及文献复习[J].福建医科大学学报,2019,53(05):360.
 ZHENG Luo,CHEN Peifang.Uterine Malignant PEComa, A Case Report and Review of Literature[J].Journal of Fujian Medical University,2019,53(02):360.
[8]金 曌,李聪慧,程 杨,等.长链非编码RNA NEAT1在银屑病中的表达及其与疾病活动度和 炎症因子水平的关联分析[J].福建医科大学学报,2020,54(01):8.
 JIN Zhao,LI Conghui,CHENG Yang,et al.The Expression of lncRNA NEAT1 and its Correlations with Disease Activity and Inflammatory Factors Level in Psoriasis Patients[J].Journal of Fujian Medical University,2020,54(02):8.

备注/Memo

备注/Memo:
收稿日期: 2019-03-25作者简介: 夏 艳,女,副主任医师通讯作者: 金志军. Email:jinzhijun108@163.com
更新日期/Last Update: 2020-04-30